Kurve Therapeutics, Inc.
PrivateLast Round
Crowdfunding
Aug 9, 2022
Est. Valuation
$341.79M
Total Funding Raised
$50M
Company Overview
Kurve Therapeutics, Inc. is a medical technology and drug formulation company that develops treatments for neurodegenerative diseases. The company's core technology is its patented Controlled Particle Dispersion® (CPD), an intranasal drug delivery system designed to bypass the blood-brain barrier. This allows for more effective delivery of therapies for complex CNS disorders, including Alzheimer's disease, Parkinson's disease, and cognitive aging. The company's lead product is ViaNase®, a device that utilizes the CPD technology. Kurve Therapeutics acquired the assets of its predecessor, Kurve Technology, Inc. (founded in 2001), in March 2022 and is advancing the technology towards Phase III clinical trials. The company is focused on developing drug/device combination therapies that offer faster, more effective drug delivery to the central nervous system with the goal of reducing side effects and costs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kurve Therapeutics, Inc. Comparables
Compare Kurve Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rocket Science Health Corp. | 83% | |
| Zeteo Biomedical | 79% | |
| MetP Pharma AG | 78% |
Kurve Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 9, 2022 |
Kurve Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kurve Therapeutics, Inc.'s valuation, stock price, and market status.
Is Kurve Therapeutics, Inc. a public or private company?
Kurve Therapeutics, Inc. is a private company.
What is the current stock price of Kurve Therapeutics, Inc.?
Kurve Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Kurve Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Kurve Therapeutics, Inc. worth (valuation)?
Kurve Therapeutics, Inc.'s valuation is estimated at $341.8M based on funding round data.
Can I buy Kurve Therapeutics, Inc. stock?
Kurve Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kurve Therapeutics, Inc.'s last funding round?
Kurve Therapeutics, Inc.'s most recent funding round was Crowdfunding on August 9, 2022.
Who are the main investors in Kurve Therapeutics, Inc.?
Investor information for Kurve Therapeutics, Inc. is not publicly disclosed.
Will Kurve Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Kurve Therapeutics, Inc..
How can I track Kurve Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kurve Therapeutics, Inc.'s secondary market activity and sign up for updates.